blog

Wouldn’t it be great if we knew all there was to know about every type of cancer cell? With this kind of knowledge, we would be able to offer personalized treatment to cancer patients that would attack their specific tumor in the most efficient way possible, improving both survival rates and quality of life during therapy. Unfortunately, we’re still facing major challenges in cancer research, right down to the level of knowing which cell samples to target with particular anti-cancer drugs. However, in a recent paper published in Nature, Barretina and colleagues go some way to providing a preclinical model system reflecting the genomic diversity of human cancers, ‘the Cancer Cell Line Encyclopedia’…

You can read the rest of this post on Terrapinn’s Total BioPharma blog.